BURT Efficacy in Improving Upper Extremity Strength and Function During Post-stroke Inpatient Rehabilitation

Last updated: December 3, 2024
Sponsor: Sunnyview Rehabilitation Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Stroke

Cerebral Ischemia

Treatment

Other Occupational Therapy

BURT

Clinical Study ID

NCT05401799
22-0324-1
  • Ages 18-115
  • All Genders

Study Summary

The Barrett Upper Extremity Robot (BURT) is an FDA-approved upper extremity robot that assists patients with both passive and active range of motion while providing adjustable resistance (Barrett_Medical. Robotic Assist Rehabilitation Made Easy. https://medical.barrett.com/). Activities are directed by therapists and encourage patient involvement through video game activities providing active proprioceptive, vibrational, visual and auditory feedback. Engaging and colorful games are beneficial in holding patients' interest, and gravity assistance may also allow for increased repetition in the face of patient fatigue.

In this prospective study, the investigators will determine if a standardized BURT Upper Extremity (UE) program can be consistently implemented within an acute inpatient rehabilitation facility (IRF). In addition, the investigators will see if patients who receive BURT have improved UE mobility and function as a result. The investigators will also study the perceived enjoyment and value of the intervention by patients, and perceived value by therapists.

Because BURT therapy is able to provide more repetitions of upper extremity movement in a shorter length of time than conventional therapy, the investigators hypothesize that patients who participate in neuro re-education activities using BURT will achieve greater improvements in strength, upper extremity function, fine motor coordination, activities of daily living and mobility during their time in an IRF than patients receiving conventional therapy.

In this study, eligible patients admitted to Sunnyview Rehabilitation Hospital (SRH) for rehabilitation following stroke will be randomized to receive conventional or BURT therapy. Meaningful clinical benchmarks for upper extremity function, tone, fine motor coordination, activities of daily living and mobility will be assessed using the Upper Extremity Motor Assessment Scale (UE-MAS)(Zelter, 2010), manual muscle testing (MMT), Modified Ashworth Scale (MAS) (Figueiredo, 2011) and the 9-hole peg test (9HPT)(Figueiredo, 2011). The investigators also hypothesize that patients in the BURT cohort will report greater value/usefulness and interest/enjoyment.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Inpatient at Sunnyview Rehabilitation Hospital

  • >/= 18 years

  • Unilateral stroke

  • UE paresis affected arm with 3-/5 or less manual muscle testing throughout

Exclusion

Exclusion Criteria:

>30 days post stroke

  • Severe Neglect

  • Bilateral stroke

  • Prior stroke with residual deficits

  • Patients receiving prism adaptation treatment

  • Comorbid neurological disorders

  • Upper limb comorbidities that could limit functional improvement (UE arthritis pain,UE fracture, fixed contracture not allowing for proper device alignment)

  • Severe shoulder subluxation that cannot be accommodated by the device

  • Severe osteoporosis

  • Unable to follow simple directions

  • Unable to tolerate sitting 30 minutes

  • Expected length of stay (LOS) < 15 days.

Study Design

Total Participants: 148
Treatment Group(s): 2
Primary Treatment: Other Occupational Therapy
Phase:
Study Start date:
September 01, 2022
Estimated Completion Date:
October 31, 2025

Connect with a study center

  • Gaylord Hospital

    Wallingford, Connecticut 06492
    United States

    Site Not Available

  • Sunnyview Rehabilitation Hospital

    Schenectady, New York 12308
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.